Shares of ANGLE plc (LON:AGL – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares trading hands.
ANGLE Price Performance
The stock has a fifty day moving average of GBX 2.35 and a 200 day moving average of GBX 3.14. The stock has a market cap of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Featured Stories
- Five stocks we like better than ANGLE
- Energy Security Is Now National Security – Positioning Is Happening Now
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
- How to collect $1,170 a month from silver
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
